Related Experiment Video
Updated: Feb 22, 2026
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer
Omer Faruk Karatas1,2, Jianghua Wang1, Longjiang Shao1
1Department of Pathology and Immunology and Michael E. DeBakey Department of Veterans Affairs Medical Center, Houston, TX, USA.
Abstract:
Prostate cancer is one of the most frequently diagnosed neoplasms among men worldwide. MicroRNAs (miRNAs) are involved in numerous important cellular processes including proliferation, differentiation and apoptosis. They have been found to be aberrantly expressed in many types of human cancers. They can act as either tumor suppressors or oncogenes, and changes in their levels are associated with tumor initiation, progression and metastasis. miR-33a is an intronic miRNA embedded within SREBF2 that has been reported to have tumor suppressive properties in some cancers but has not been examined in prostate cancer. SREBF2 increases cholesterol and lipid levels both directly and via miR-33a action. The levels of SREBF2 and miR-33a are correlated in normal tissues by co-transcription from the same gene locus. Paradoxically, SREBF2 has been reported to be increased in prostate cancer, which would be predicted to increase miR-33a levels potentially leading to tumor suppression. We show here that miR-33a has tumor suppressive activities and is decreased in prostate cancer. The decreased miR-33a increases mRNA for the PIM1 oncogene and multiple genes in the lipid β-oxidation pathway. Levels of miR-33a are not correlated with SREBF2 levels, implying posttranscriptional regulation of its expression in prostate cancer.
Insights
MicroRNAs (miRNAs) like miR-33a are crucial in cancer. This study reveals miR-33a acts as a tumor suppressor and is decreased in prostate cancer, promoting oncogene PIM1 and lipid metabolism.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer is a leading cancer diagnosis in men globally.
- MicroRNAs (miRNAs) regulate cellular processes and are implicated in various cancers, acting as tumor suppressors or oncogenes.
- miR-33a, embedded within SREBF2, has shown tumor-suppressive roles in some cancers but its function in prostate cancer was unexamined.
Purpose of the Study:
- To investigate the role of miR-33a in prostate cancer.
- To determine miR-33a expression levels in prostate cancer tissues.
- To identify downstream targets of miR-33a in prostate cancer.
Main Methods:
- Analysis of miR-33a and SREBF2 expression in prostate cancer.
- Investigating the functional role of miR-33a in prostate cancer cells.
- Identifying mRNA targets of miR-33a using bioinformatics and experimental validation.
Main Results:
- miR-33a exhibits tumor-suppressive activities in prostate cancer.
- miR-33a levels are significantly decreased in prostate cancer tissues.
- Decreased miR-33a correlates with increased PIM1 oncogene and lipid β-oxidation pathway gene expression.
- miR-33a and SREBF2 expression levels are uncorrelated in prostate cancer, suggesting posttranscriptional regulation.
Conclusions:
- miR-33a functions as a tumor suppressor in prostate cancer.
- Reduced miR-33a contributes to prostate cancer progression by upregulating oncogenes and lipid metabolism.
- Posttranscriptional mechanisms likely regulate miR-33a expression in prostate cancer.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...